Aida Pharmaceuticals
(OTC) AIDA
Aida Pharmaceuticals Financials at a Glance
Market Cap
$8,100
Revenue (TTM)
$40.95M
Net Income (TTM)
$2.09M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-4.51 (Low)
Dividend
$0.00
Beta (Volatility)
-4.51 (Low)
Price
$0.00
Volume
500
Open
$0.00
Price
$0.00
Volume
500
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
-4.51 (Low)
Price
$0.00
Volume
500
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
AIDA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Aida Pharmaceuticals
AIDA Financials
Key Financial Metrics (TTM)
Gross Margin
50%
Operating Margin
19%
Net Income Margin
9%
Return on Equity
0%
Return on Capital
23%
Return on Assets
4%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$8.10K
Shares Outstanding
27.00M
Volume
500
Avg. Volume
0
Financials (TTM)
Gross Profit
$14.69M
Operating Income
$5.45M
EBITDA
$7.32M
Operating Cash Flow
$8.39M
Capital Expenditure
$3.61M
Free Cash Flow
$4.78M
Cash & ST Invst.
$18.95M
Total Debt
$33.37M
Aida Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$11.88M
+61.2%
Gross Profit
$6.93M
+81.5%
Gross Margin
58.28%
N/A
Market Cap
$8.10K
N/A
Market Cap/Employee
$18.00
N/A
Employees
450
N/A
Net Income
$2.29M
+341.2%
EBITDA
$3.36M
+76.7%
Quarterly Fundamentals
Net Cash
$31.18M
-24.9%
Accounts Receivable
$12.31M
-1.7%
Inventory
$5.47M
+32.4%
Long Term Debt
$8.61M
+348.0%
Short Term Debt
$32.55M
+5.9%
Return on Assets
4.37%
N/A
Return on Invested Capital
22.82%
N/A
Free Cash Flow
$403.99K
-114.4%
Operating Cash Flow
$2.15M
-51.8%